BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 29378150)

  • 1. Dithiothreitol treatment of red blood cells.
    Bub CB
    Immunohematology; 2017 Dec; 33(4):170-172. PubMed ID: 29378150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of Modified DTT Methods to Reduce the Interference of Daratumumab on Serological Detection].
    Li YY; Zhang L; Cai K; Wu MH; Zhu LR; Li CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1543-1549. PubMed ID: 37846714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELP protocol: an original approach for the mitigation of anti-CD38 interference.
    Maiorana E; Bortolati M; Croitoru S; Llanaj G; Ongaro C; Polga E; Salvo M; Sandini A; Succoli K; Tortomasi T; Vicino G; Fiorin F
    Blood Transfus; 2024 Jun; ():. PubMed ID: 38949853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do transfusion services manage patients taking therapies such as anti-CD38 and anti-CD47 known to interfere with red blood cell compatibility testing?
    Murphy MF; Rajbhandary S; Carayiannis S; Cohn CS
    Transfusion; 2024 May; ():. PubMed ID: 38767410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion management for patients taking an anti-CD38 monoclonal antibody.
    Bub CB; Reis IND; Aravechia MG; Santos LD; Bastos EP; Kutner JM; Castilho L
    Rev Bras Hematol Hemoter; 2018; 40(1):25-29. PubMed ID: 29519368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rouleaux and saline replacement.
    Waider KL
    Immunohematology; 2018 Sep; 34(3):91-92. PubMed ID: 30295502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of chloroquine diphosphate in the blood bank laboratory.
    Aye T; Arndt PA
    Immunohematology; 2018 Sep; 34(3):98-102. PubMed ID: 30295504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method).
    Hosokawa M; Kashiwagi H; Nakayama K; Sakuragi M; Nakao M; Morikawa T; Kiyokawa T; Aochi H; Nagamine K; Shibayama H; Tomiyama Y
    Transfusion; 2018 Dec; 58(12):3003-3013. PubMed ID: 30267414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New method for overcoming the interference produced by anti-CD38 monoclonal antibodies in compatibility testing.
    Izaguirre EC; Del Mar Luis-Hidalgo M; González LL; Castaño CA
    Blood Transfus; 2020 Jul; 18(4):290-294. PubMed ID: 32530397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutination Inhibition Assay.
    Spackman E; Sitaras I
    Methods Mol Biol; 2020; 2123():11-28. PubMed ID: 32170677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZZAP treatment of red blood cells.
    Marckwardt SI
    Immunohematology; 2019 Jan; 35(1):9-10. PubMed ID: 30908071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
    Carr ME; Zekert SL
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Column agglutination technology: the antiglobulin test.
    Reis KJ; Chachowski R; Cupido A; Davies D; Jakway J; Setcavage TM
    Transfusion; 1993 Aug; 33(8):639-43. PubMed ID: 8342229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new reagent (ZZAP) having multiple applications in immunohematology.
    Branch DR; Petz LD
    Am J Clin Pathol; 1982 Aug; 78(2):161-7. PubMed ID: 6808844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dithiothreitol treatment of red blood cells.
    Bub CB
    Immunohematology; 2019; 33(4):170-172. PubMed ID: 34841820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of ABO Antibodies in Group O Malaysian Blood Donors.
    Saidin NIS; Noor NHM; Yusoff SM; Sauli MS
    Malays J Med Sci; 2023 Aug; 30(4):61-70. PubMed ID: 37655148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Effects of anti-CD38 monoclonal antibodies on red blood cell transfusion and interventions.
    Song J; Fu R
    J Clin Lab Anal; 2021 Dec; 35(12):e23832. PubMed ID: 34752645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Manual Polybrene Method Can Be Used for the Pretransfusion Test to Mitigate Daratumumab Interference without a Supplementary Antiglobulin Test.
    Shao LN; Wang N; Yu WJ; Zhou SH
    Transfus Med Hemother; 2021 Mar; 48(2):130-131. PubMed ID: 33976613
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies.
    Lancman G; Arinsburg S; Jhang J; Cho HJ; Jagannath S; Madduri D; Parekh S; Richter J; Chari A
    Front Immunol; 2018; 9():2616. PubMed ID: 30498492
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.